Evaluation of Novel Agents Which Target Neovasculature of Breast Tumors

作者: Michael Rosenblum

DOI: 10.21236/ADA439833

关键词:

摘要: Abstract : Biological studies examining the development of vascular tree in normal and disease states have identified numerous cytokines their receptors responsible for triggering maintaining this process (1-7). Tumor neovascularization is central not only to growth primary lesion but appears be a critical factor maintenance metastases (8-12). Clinical bladder cancer (9) demonstrated correlation between micro-vessel density metastases. In addition, breast by Fox et al. Aranda (11-12) that microvessel count tumors related presence lymph nodes micrometastases bone marrow. The cytokine endothelial factor-A (VEGF-A) its Flt-1 KDR been implicated as one mediators angiogenesis tumor (13-20). Up-regulation or over-expression VEGF-A ligand itself poor prognostic markers various clinical colon, pituitary cancers (21-23). Recently, Padro (24) suggested both may play role observed marrow during AML progression provide evidence VEGF/KDR pathway important leukemic growth.

参考文章(72)
L. M. Veenendaal, H. Jin, S. Ran, L. Cheung, N. Navone, J. W. Marks, J. Waltenberger, P. Thorpe, M. G. Rosenblum, In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 7866- 7871 ,(2002) , 10.1073/PNAS.122157899
R.Barbara Pedley, Ethaar El-Emir, Aiden A Flynn, Geoffrey M Boxer, Jason Dearling, James A Raleigh, Sally A Hill, Sam Stuart, Reeya Motha, Richard H.J Begent, Synergy between vascular targeting agents and antibody-directed therapy. International Journal of Radiation Oncology Biology Physics. ,vol. 54, pp. 1524- 1531 ,(2002) , 10.1016/S0360-3016(02)03923-8
K. Axelsson, B.-M. E. Ljung, D. H. Moore, A. D. Thor, K. L. Chew, S. M. Edgerton, H. S. Smith, B. H. Mayall, Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast Carcinoma Journal of the National Cancer Institute. ,vol. 87, pp. 997- 1008 ,(1995) , 10.1093/JNCI/87.13.997
Mukesh D. Hariawala, Jeffrey R. Horowitz, Darryl Esakof, Don D. Sheriff, Dirk H. Walter, Bruce Keyt, Jeffrey M. Isner, James F. Symes, VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. Journal of Surgical Research. ,vol. 63, pp. 77- 82 ,(1996) , 10.1006/JSRE.1996.0226
MICHAEL G. ROSENBLUM, WILLIAM A. KOHR, KENNETH L. BEATTIE, WANDA G. BEATTIE, WILLIAM MARKS, P. DAVID TOMAN, LAWRENCE CHEUNG, Amino Acid Sequence Analysis, Gene Construction, Cloning, and Expression of Gelonin, a Toxin Derived from Gelonium multiflorum Journal of Interferon and Cytokine Research. ,vol. 15, pp. 547- 555 ,(1995) , 10.1089/JIR.1995.15.547
Silvano Bosari, Arthur K.C. Lee, Ronald A. DeLellis, Brian D. Wiley, Gerald J. Heatley, Mark L. Silverman, Microvessel quantitation and prognosis in invasive breast carcinoma Human Pathology. ,vol. 23, pp. 755- 761 ,(1992) , 10.1016/0046-8177(92)90344-3
Rumi Murata, Jens Overgaard, Michael R Horsman, Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy International Journal of Radiation Oncology Biology Physics. ,vol. 51, pp. 1018- 1024 ,(2001) , 10.1016/S0360-3016(01)01742-4
C. J. McCabe, K. Boelaert, L. A. Tannahill, A. P. Heaney, A. L. Stratford, J. S. Khaira, S. Hussain, M. C. Sheppard, J. A. Franklyn, N. J. L. Gittoes, Vascular Endothelial Growth Factor, Its Receptor KDR/Flk-1, and Pituitary Tumor Transforming Gene in Pituitary Tumors The Journal of Clinical Endocrinology and Metabolism. ,vol. 87, pp. 4238- 4244 ,(2002) , 10.1210/JC.2002-020309